Go Pro

Privia Health Group (PRVA) Competitors

Privia Health Group logo
$23.67 -0.19 (-0.80%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$23.68 +0.00 (+0.02%)
As of 07/31/2026 05:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

PRVA vs. PACS, HIMS, BLLN, SHC, and RDNT

Should you buy Privia Health Group stock or one of its competitors? MarketBeat compares Privia Health Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Privia Health Group include PACS Group (PACS), Hims & Hers Health (HIMS), Billiontoone (BLLN), Sotera Health (SHC), and RadNet (RDNT).

How does Privia Health Group compare to PACS Group?

PACS Group (NYSE:PACS) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

In the previous week, PACS Group had 2 more articles in the media than Privia Health Group. MarketBeat recorded 6 mentions for PACS Group and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.27 beat PACS Group's score of 0.98 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
4 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.5% of Privia Health Group shares are held by institutional investors. 70.1% of PACS Group shares are held by insiders. Comparatively, 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

PACS Group currently has a consensus target price of $50.60, indicating a potential upside of 9.72%. Privia Health Group has a consensus target price of $31.15, indicating a potential upside of 31.62%. Given Privia Health Group's higher possible upside, analysts plainly believe Privia Health Group is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

PACS Group has a net margin of 4.49% compared to Privia Health Group's net margin of 0.97%. PACS Group's return on equity of 26.47% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Privia Health Group 0.97%2.81%1.61%

PACS Group has a beta of -0.08, meaning that its stock price is 108% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

PACS Group has higher revenue and earnings than Privia Health Group. PACS Group is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.38$191.54M$1.5629.56
Privia Health Group$2.12B1.41$22.92M$0.16147.94

Summary

PACS Group beats Privia Health Group on 8 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Hims & Hers Health?

Privia Health Group (NASDAQ:PRVA) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends.

Hims & Hers Health has higher revenue and earnings than Privia Health Group. Hims & Hers Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.41$22.92M$0.16147.94
Hims & Hers Health$2.35B2.74$128.37M-$0.09N/A

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Privia Health Group has a net margin of 0.97% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group0.97% 2.81% 1.61%
Hims & Hers Health -0.56%6.10%1.52%

Privia Health Group currently has a consensus target price of $31.15, suggesting a potential upside of 31.62%. Hims & Hers Health has a consensus target price of $31.43, suggesting a potential upside of 13.12%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts clearly believe Privia Health Group is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19

Privia Health Group has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.35, suggesting that its share price is 135% more volatile than the broader market.

In the previous week, Hims & Hers Health had 22 more articles in the media than Privia Health Group. MarketBeat recorded 26 mentions for Hims & Hers Health and 4 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 1.27 beat Hims & Hers Health's score of 0.22 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
6 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
6 Negative mention(s)
2 Very Negative mention(s)
Neutral

Summary

Privia Health Group beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, valuation, earnings, profitability and media sentiment.

Billiontoone currently has a consensus target price of $126.00, suggesting a potential downside of 9.09%. Privia Health Group has a consensus target price of $31.15, suggesting a potential upside of 31.62%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

Privia Health Group has a net margin of 0.97% compared to Billiontoone's net margin of 0.00%. Privia Health Group's return on equity of 2.81% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
Privia Health Group 0.97%2.81%1.61%

94.5% of Privia Health Group shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by insiders. Comparatively, 5.7% of Privia Health Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Privia Health Group has higher revenue and earnings than Billiontoone. Privia Health Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M20.89$7.45M$0.55252.00
Privia Health Group$2.12B1.41$22.92M$0.16147.94

In the previous week, Privia Health Group had 1 more articles in the media than Billiontoone. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for Billiontoone. Privia Health Group's average media sentiment score of 1.27 beat Billiontoone's score of 0.10 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Privia Health Group beats Billiontoone on 11 of the 15 factors compared between the two stocks.

How does Privia Health Group compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

Sotera Health has higher earnings, but lower revenue than Privia Health Group. Sotera Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.38$77.94M$0.4143.56
Privia Health Group$2.12B1.41$22.92M$0.16147.94

Sotera Health has a net margin of 9.91% compared to Privia Health Group's net margin of 0.97%. Sotera Health's return on equity of 39.73% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
Privia Health Group 0.97%2.81%1.61%

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sotera Health has a beta of 1.76, meaning that its share price is 76% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market.

Sotera Health presently has a consensus price target of $20.25, suggesting a potential upside of 13.38%. Privia Health Group has a consensus price target of $31.15, suggesting a potential upside of 31.62%. Given Privia Health Group's higher possible upside, analysts plainly believe Privia Health Group is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

In the previous week, Sotera Health had 8 more articles in the media than Privia Health Group. MarketBeat recorded 12 mentions for Sotera Health and 4 mentions for Privia Health Group. Sotera Health's average media sentiment score of 1.32 beat Privia Health Group's score of 1.27 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
9 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Sotera Health beats Privia Health Group on 11 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

RadNet (NASDAQ:RDNT) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, earnings, profitability, risk, analyst recommendations, dividends and media sentiment.

RadNet presently has a consensus target price of $87.43, indicating a potential upside of 37.08%. Privia Health Group has a consensus target price of $31.15, indicating a potential upside of 31.62%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
RadNet
2 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.80
Privia Health Group
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

Privia Health Group has a net margin of 0.97% compared to RadNet's net margin of -0.66%. Privia Health Group's return on equity of 2.81% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
RadNet-0.66% 2.77% 0.97%
Privia Health Group 0.97%2.81%1.61%

77.9% of RadNet shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 5.6% of RadNet shares are held by company insiders. Comparatively, 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Privia Health Group had 1 more articles in the media than RadNet. MarketBeat recorded 4 mentions for Privia Health Group and 3 mentions for RadNet. Privia Health Group's average media sentiment score of 1.27 beat RadNet's score of 0.99 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
RadNet
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

RadNet has a beta of 1.37, suggesting that its share price is 37% more volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market.

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
RadNet$2.04B2.46-$18.65M-$0.18N/A
Privia Health Group$2.12B1.41$22.92M$0.16147.94

Summary

Privia Health Group beats RadNet on 12 of the 17 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRVA vs. The Competition

MetricPrivia Health GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$2.98B$9.87B$7.16B$12.47B
Dividend YieldN/A2.52%2.60%9.45%
P/E Ratio147.9525.44282.2524.66
Price / Sales1.414.77585.8490.59
Price / Cash88.69125.6671.2359.99
Price / Book3.685.1311.095.90
Net Income$22.92M$311.13M$3.50B$336.31M
7 Day Performance-7.18%-0.29%-0.24%0.09%
1 Month Performance-13.49%-1.50%-3.70%-5.18%
1 Year Performance25.50%26.23%61.98%18.61%

Privia Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
4.761 of 5 stars
$23.67
-0.8%
$31.15
+31.6%
+25.5%$2.98B$2.12B147.951,226
PACS
PACS Group
3.2792 of 5 stars
$46.81
-0.6%
$50.60
+8.1%
+334.3%$7.42B$5.43B30.0647,455
HIMS
Hims & Hers Health
2.9509 of 5 stars
$28.62
-5.4%
$31.43
+9.8%
-55.6%$6.56B$2.37BN/A2,442
BLLN
Billiontoone
2.3588 of 5 stars
$132.69
+3.7%
$126.00
-5.0%
N/A$6.11B$305.11M241.42620
SHC
Sotera Health
3.88 of 5 stars
$17.51
+1.5%
$20.25
+15.7%
+60.2%$4.98B$1.19B42.603,000

Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners